Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

Yoon Seong Kim1, Tong H Joh

  • 1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10021, USA. yok2001@med.cornell.edu

Insights

Chronic inflammation contributes to neurodegenerative diseases like Alzheimer's and Parkinson's. Activated microglia, immune cells in the brain, can harm neurons, exacerbating these conditions.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Inflammation is a defense mechanism that can become detrimental.
  • Chronic inflammation is linked to neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis.
  • Microglia are the primary immune cells in the central nervous system, playing a key role in neuroinflammation.

Purpose of the Study:

  • To review microglial responses to neuronal damage.
  • To discuss activators released by injured neurons.
  • To explore how microglia contribute to neuronal degeneration, with a focus on Parkinson's disease.

Main Methods:

  • Literature review of microglial activation and neuroinflammation.
  • Analysis of the role of microglia in neuronal damage.
  • In-depth discussion of microglial involvement in Parkinson's disease.

Main Results:

  • Uncontrolled microglial activation can be toxic to neurons.
  • Microglia release inflammatory cytokines (e.g., IL-1beta, TNF-alpha, IL-6), nitric oxide (NO), PGE(2), and superoxide.
  • Activated microglia phagocytose not only debris but also intact neighboring cells, perpetuating neuronal damage cycles.

Conclusions:

  • Microglia are critical in neuroinflammation and neurodegenerative processes.
  • Understanding microglial behavior is key to developing treatments for diseases like Parkinson's.
  • Dysregulated microglial activity contributes significantly to neuronal loss in neurodegenerative disorders.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Glial Cells01:04

Glial Cells

Overview
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.